465 related articles for article (PubMed ID: 16316560)
1. [The prognostic value of end-stage liver disease model in liver cirrhosis].
Zhang JY; Zhang FK; Wang BE; Jia JD; Zhang ST
Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):822-4. PubMed ID: 16316560
[TBL] [Abstract][Full Text] [Related]
2. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
3. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
Hassan EA; Abd El-Rehim AS
Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
[TBL] [Abstract][Full Text] [Related]
4. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
[TBL] [Abstract][Full Text] [Related]
5. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
[TBL] [Abstract][Full Text] [Related]
6. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
Li JY; Deng Q; Wang Y; Xu MY; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
[TBL] [Abstract][Full Text] [Related]
9. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
Mishra P; Desai N; Alexander J; Singh DP; Sawant P
J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
[TBL] [Abstract][Full Text] [Related]
10. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.
Corneille MG; Nicholson S; Richa J; Son C; Michalek J; Wolf SE; Stewart R
J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
[TBL] [Abstract][Full Text] [Related]
12. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
Jiang ZS; Jiang JN
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
[TBL] [Abstract][Full Text] [Related]
13. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.
Limquiaco JL; Wong GL; Wong VW; Lai PB; Chan HL
J Gastroenterol Hepatol; 2009 Jan; 24(1):63-9. PubMed ID: 19054256
[TBL] [Abstract][Full Text] [Related]
15. Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt.
Zhang F; Zhuge Y; Zou X; Zhang M; Peng C; Li Z; Wang T
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):853-60. PubMed ID: 24915489
[TBL] [Abstract][Full Text] [Related]
16. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
[TBL] [Abstract][Full Text] [Related]
17. [Serum sodium concentration profile for cirrhotic patients and its effect on the prognostic value of the MELD score].
Zhang JY; Qin CY; Jia JD; Wang BE
Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):108-11. PubMed ID: 22464781
[TBL] [Abstract][Full Text] [Related]
18. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
[TBL] [Abstract][Full Text] [Related]
19. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
Londoño MC; Cárdenas A; Guevara M; Quintó L; de Las Heras D; Navasa M; Rimola A; Garcia-Valdecasas JC; Arroyo V; Ginès P
Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of CTP, MELD, and MELD-Na scores for predicting short term mortality in patients with liver cirrhosis].
Kim SY; Yim HJ; Lee J; Lee BJ; Kim DI; Jung SW; Han WS; Lee JS; Koo JS; Seo YS; Yeon JE; Lee HS; Lee SW; Um SH; Byun KS; Choi JH; Ryu HS
Korean J Gastroenterol; 2007 Aug; 50(2):92-100. PubMed ID: 17928752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
